Dysregulated WNT5a signaling is observed in many lung diseases, ranging from chronic obstructive pulmonary disease (COPD) [12] and idiopathic pulmonary fibrosis (UIP/IPF) [13] to asthma [14]. This evidence concerns the gene WNT5A and chronic obstructive pulmonary disease.